Wolfgang Renner: Immunostimulatory Nanoparticles for the Treatment of Allergic Asthma: Results from a Placebo-controlled Phase II Study (2011)

Allergen-free therapies for chronic allergic conditions such as rhinoconjunctivitis and asthma are under development. Wolfgang Renner explains how he hopes to eliminate the cause of allergic asthmatic inflammation, thus offering patients an alternative to replace or complement commonly used medications, while maintaining or even improving asthma control.